Jump to content

Xu Jingren: Difference between revisions

Edit links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
Correct date
→‎Family: Clean
 
Line 22: Line 22:
'''Xu Jingren''' ({{zh|s=徐镜人}}; September 15, 1944 – July 12, 2021) was the chairman and president of [[Yangtze River Pharmaceutical Group]],<ref name=bberg>{{cite web|title=Company Overview of Jiangsu Yangtze River Pharmaceutical Group Company Ltd.|url=https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=40239651|website=Bloomberg.com/|publisher=Bloomberg Business}}</ref> [[National People's Congress]] delegate and honorary vice-minister in China's [[Ministry of Health (China)|Ministry of Health]]. Xu had been an outspoken research leader in China, where he had frequently called for labor reform and business regulation.<ref name=npc>{{cite web|title=Deputy: cost cutting affects public health|url=http://www.npc.gov.cn/englishnpc/Special_11_5/2012-03/14/content_1713569.htm|website=Npc.gov.cn|publisher=NPC}}</ref> As of 2021, his estimated net worth was [[USD]]$4.6 billion,<ref name=forbes>{{cite web|title=Xu Jingren Net Worth|url=https://www.forbes.com/profile/xu-jingren/|website=Forbes.com}}</ref> one of four family members to be listed among the world's wealthiest. He died on 12 July 2021.<ref>{{Cite web|url=https://www.yicai.com/news/101108353.html|title = 扬子江药业董事长徐镜人7月12日晚离世，曾表示坚持不上市}}</ref>
'''Xu Jingren''' ({{zh|s=徐镜人}}; September 15, 1944 – July 12, 2021) was the chairman and president of [[Yangtze River Pharmaceutical Group]],<ref name=bberg>{{cite web|title=Company Overview of Jiangsu Yangtze River Pharmaceutical Group Company Ltd.|url=https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=40239651|website=Bloomberg.com/|publisher=Bloomberg Business}}</ref> [[National People's Congress]] delegate and honorary vice-minister in China's [[Ministry of Health (China)|Ministry of Health]]. Xu had been an outspoken research leader in China, where he had frequently called for labor reform and business regulation.<ref name=npc>{{cite web|title=Deputy: cost cutting affects public health|url=http://www.npc.gov.cn/englishnpc/Special_11_5/2012-03/14/content_1713569.htm|website=Npc.gov.cn|publisher=NPC}}</ref> As of 2021, his estimated net worth was [[USD]]$4.6 billion,<ref name=forbes>{{cite web|title=Xu Jingren Net Worth|url=https://www.forbes.com/profile/xu-jingren/|website=Forbes.com}}</ref> one of four family members to be listed among the world's wealthiest. He died on 12 July 2021.<ref>{{Cite web|url=https://www.yicai.com/news/101108353.html|title = 扬子江药业董事长徐镜人7月12日晚离世，曾表示坚持不上市}}</ref>


==Family==
==Personal life==
The family were noted victims of the [[2015 Chinese stock market crash]], during which they lost approximately 40% of their previously estimated [[USD]]$8 billion combined net worth.<ref name="FB1">{{cite web|title=China's Richest Billionaires Lost $195 Billion In One Month Amid Stock Market Rout|url=https://www.forbes.com/sites/liyanchen/2015/07/08/chinas-richest-billionaires-lost-195-billion-in-one-month-amid-stock-market-rout/|website=Forbes.com|access-date=22 October 2015}}</ref> Despite this, Xu Jingren and his relatives continue to be mentioned as one of China's top "vampire billionaire" families with majority investments abroad.<ref name="CNN">{{cite web|last1=Lu Stout|first1=Kristie|title=Meet China's 1%: The billionaires in Beijing's halls of power|url=http://edition.cnn.com/2015/07/22/china/china-ultra-rich-politics/|website=edition.cnn.com/|date=23 July 2015 |publisher=CNN|access-date=22 October 2015}}</ref><ref name="CNN2">{{cite web|last1=Hoogewerf|first1=Richard|title=Who are China's 'vampire' billionaires?|url=https://money.cnn.com/video/news/economy/2015/07/21/china-vampire-billionaires.cnnmoney/|website=money.cnn.com/|publisher=CNN|access-date=22 October 2015}}</ref><ref name="TG2">{{cite web|last1=Branigan|first1=Tania|title=Politburo, army, casinos: China's corruption crackdown spreads|url=https://www.theguardian.com/world/2015/feb/14/china-corruption-crackdown-spreads-xi-jinping|website=Theguardian.com|date=14 February 2015|publisher=The Guardian UK|access-date=22 October 2015}}</ref> Notable international initiatives include the 2017 YRPG subsidiary<ref>{{Cite web|url=https://www.cphi.com/sea/exhibitors/yangtze-river-pharmaceuticalgroup-co|title=Yangtze River Pharmaceutical(Group) Co.|date=11 January 2019|website=CPhI SEA {{!}} Bangkok is Calling|language=en|access-date=19 December 2019}}</ref> merger and rebranding of global drug manufacturer ShangPharma<ref>{{Cite press release|url=https://www.prnewswire.com/news-releases/shangpharma-corporation-announces-completion-of-merger-200373101.html|title=ShangPharma Corporation Announces Completion of Merger|last=Corporation|first=ShangPharma|website=www.prnewswire.com|language=en|access-date=19 December 2019}}</ref> by group CEO Michael Hui and board vice-chair Aaron Shang, with a stated intent of expanding North American operations leading to development of [[San Francisco]]-based venture portfolio ShangPharma Innovation.<ref>{{Cite web|url=https://www.chempartner.com/2017/06/19/shangpharma-announces-second-milestone-in-move-to-enter-chinese-capital-market/|title=ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market|date=2017|website=ChemPartner.com}}</ref><ref>{{Cite web|url=https://www.bizjournals.com/sanfrancisco/news/2018/07/12/shangpharma-innovation-incubator-china-vc.html|title=How this Chinese biotech player is building and boosting a network of startups|website=www.bizjournals.com|access-date=19 December 2019}}</ref><ref>{{Cite web|url=https://www.biospace.com/article/shangpharma-innovation-incubator-expansion-is-taking-strong-root-in-the-bay-area/|title=ShangPharma Innovation Incubator Expansion Is Taking Strong Root in the Bay Area|website=BioSpace|language=en-US|access-date=19 December 2019}}</ref>
The family were noted victims of the [[2015 Chinese stock market crash]], during which they lost approximately 40% of their previously estimated [[USD]]$8 billion combined net worth.<ref name="FB1">{{cite web|title=China's Richest Billionaires Lost $195 Billion In One Month Amid Stock Market Rout|url=https://www.forbes.com/sites/liyanchen/2015/07/08/chinas-richest-billionaires-lost-195-billion-in-one-month-amid-stock-market-rout/|website=Forbes.com|access-date=22 October 2015}}</ref> Despite this, Xu Jingren and his relatives continue to be mentioned as one of China's top "vampire billionaire" families with majority investments abroad.<ref name="CNN">{{cite web|last1=Lu Stout|first1=Kristie|title=Meet China's 1%: The billionaires in Beijing's halls of power|url=http://edition.cnn.com/2015/07/22/china/china-ultra-rich-politics/|website=edition.cnn.com/|date=23 July 2015 |publisher=CNN|access-date=22 October 2015}}</ref><ref name="CNN2">{{cite web|last1=Hoogewerf|first1=Richard|title=Who are China's 'vampire' billionaires?|url=https://money.cnn.com/video/news/economy/2015/07/21/china-vampire-billionaires.cnnmoney/|website=money.cnn.com/|publisher=CNN|access-date=22 October 2015}}</ref><ref name="TG2">{{cite web|last1=Branigan|first1=Tania|title=Politburo, army, casinos: China's corruption crackdown spreads|url=https://www.theguardian.com/world/2015/feb/14/china-corruption-crackdown-spreads-xi-jinping|website=Theguardian.com|date=14 February 2015|publisher=The Guardian UK|access-date=22 October 2015}}</ref> Notable international initiatives include the 2017 YRPG subsidiary<ref>{{Cite web|url=https://www.cphi.com/sea/exhibitors/yangtze-river-pharmaceuticalgroup-co|title=Yangtze River Pharmaceutical(Group) Co.|date=11 January 2019|website=CPhI SEA {{!}} Bangkok is Calling|language=en|access-date=19 December 2019}}</ref> merger and rebranding of global drug manufacturer ShangPharma<ref>{{Cite press release|url=https://www.prnewswire.com/news-releases/shangpharma-corporation-announces-completion-of-merger-200373101.html|title=ShangPharma Corporation Announces Completion of Merger|last=Corporation|first=ShangPharma|website=www.prnewswire.com|language=en|access-date=19 December 2019}}</ref> by group CEO Michael Hui and board vice-chair Aaron Shang, with a stated intent of expanding North American operations leading to development of [[San Francisco]]-based venture portfolio ShangPharma Innovation.<ref>{{Cite web|url=https://www.chempartner.com/2017/06/19/shangpharma-announces-second-milestone-in-move-to-enter-chinese-capital-market/|title=ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market|date=2017|website=ChemPartner.com}}</ref><ref>{{Cite web|url=https://www.bizjournals.com/sanfrancisco/news/2018/07/12/shangpharma-innovation-incubator-china-vc.html|title=How this Chinese biotech player is building and boosting a network of startups|website=www.bizjournals.com|access-date=19 December 2019}}</ref><ref>{{Cite web|url=https://www.biospace.com/article/shangpharma-innovation-incubator-expansion-is-taking-strong-root-in-the-bay-area/|title=ShangPharma Innovation Incubator Expansion Is Taking Strong Root in the Bay Area|website=BioSpace|language=en-US|access-date=19 December 2019}}</ref>


Latest revision as of 20:37, 27 June 2024

In this Chinese name, the family name is Xu.
Xu Jingren
徐镜人
Born15 September 1944
Taizhou, Jiangsu, China
Died12 July 2021(2021-07-12) (aged 76)
EducationB.A.
Occupation(s)Pharmaceutical executive, philanthropist
Children2

Xu Jingren (Chinese: 徐镜人; September 15, 1944 – July 12, 2021) was the chairman and president of Yangtze River Pharmaceutical Group,[1] National People's Congress delegate and honorary vice-minister in China's Ministry of Health. Xu had been an outspoken research leader in China, where he had frequently called for labor reform and business regulation.[2] As of 2021, his estimated net worth was USD$4.6 billion,[3] one of four family members to be listed among the world's wealthiest. He died on 12 July 2021.[4]

Personal life

[edit]

The family were noted victims of the 2015 Chinese stock market crash, during which they lost approximately 40% of their previously estimated USD$8 billion combined net worth.[5] Despite this, Xu Jingren and his relatives continue to be mentioned as one of China's top "vampire billionaire" families with majority investments abroad.[6][7][8] Notable international initiatives include the 2017 YRPG subsidiary[9] merger and rebranding of global drug manufacturer ShangPharma[10] by group CEO Michael Hui and board vice-chair Aaron Shang, with a stated intent of expanding North American operations leading to development of San Francisco-based venture portfolio ShangPharma Innovation.[11][12][13]

References

[edit]
  1. ^ "Company Overview of Jiangsu Yangtze River Pharmaceutical Group Company Ltd". Bloomberg.com/. Bloomberg Business.
  2. ^ "Deputy: cost cutting affects public health". Npc.gov.cn. NPC.
  3. ^ "Xu Jingren Net Worth". Forbes.com.
  4. ^ "扬子江药业董事长徐镜人7月12日晚离世，曾表示坚持不上市".
  5. ^ "China's Richest Billionaires Lost $195 Billion In One Month Amid Stock Market Rout". Forbes.com. Retrieved 22 October 2015.
  6. ^ Lu Stout, Kristie (23 July 2015). "Meet China's 1%: The billionaires in Beijing's halls of power". edition.cnn.com/. CNN. Retrieved 22 October 2015.
  7. ^ Hoogewerf, Richard. "Who are China's 'vampire' billionaires?". money.cnn.com/. CNN. Retrieved 22 October 2015.
  8. ^ Branigan, Tania (14 February 2015). "Politburo, army, casinos: China's corruption crackdown spreads". Theguardian.com. The Guardian UK. Retrieved 22 October 2015.
  9. ^ "Yangtze River Pharmaceutical(Group) Co". CPhI SEA | Bangkok is Calling. 11 January 2019. Retrieved 19 December 2019.
  10. ^ Corporation, ShangPharma. "ShangPharma Corporation Announces Completion of Merger". www.prnewswire.com (Press release). Retrieved 19 December 2019.
  11. ^ "ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market". ChemPartner.com. 2017.
  12. ^ "How this Chinese biotech player is building and boosting a network of startups". www.bizjournals.com. Retrieved 19 December 2019.
  13. ^ "ShangPharma Innovation Incubator Expansion Is Taking Strong Root in the Bay Area". BioSpace. Retrieved 19 December 2019.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Xu_Jingren&oldid=1231345599"